Literature DB >> 21915360

The molecular epidemiology of variant CJD.

Graham A Mackay1, Richard Sg Knight, James W Ironside.   

Abstract

The emergence of the novel prion diseases bovine spongiform encephalopathy (BSE) and, subsequently, variant Creutzfeldt-Jakob disease (vCJD) in epidemic forms has attracted much scientific attention. The oral transmission of these disorders, the causative relationship of vCJD to BSE and the resistance of the transmissible agents in both disorders to conventional forms of decontamination has caused great public health concern. The size of the still emerging vCJD epidemic is thankfully much lower than some early published estimates. This paper reviews current knowledge of the factors that influence the development of vCJD: the properties of the infectious agent; the route of inoculation and individual susceptibility factors. The current epidemiological data are reviewed, along with relevant animal transmission studies. In terms of genetic susceptibility, the best characterised is the common single nucleotide polymorphism at codon 129 of prion protein gene. Current biomarkers and future areas of research will be discussed. These issues are important in informing precautionary measures and the ongoing monitoring of vCJD.

Entities:  

Keywords:  BSE; Variant CJD; biomarkers; environmental factors; genetic factors; investigations; prion disease; susceptibility; transmission

Year:  2011        PMID: 21915360      PMCID: PMC3166149     

Source DB:  PubMed          Journal:  Int J Mol Epidemiol Genet        ISSN: 1948-1756


  57 in total

1.  Predicting susceptibility and incubation time of human-to-human transmission of vCJD.

Authors:  M T Bishop; P Hart; L Aitchison; H N Baybutt; C Plinston; V Thomson; N L Tuzi; M W Head; J W Ironside; R G Will; J C Manson
Journal:  Lancet Neurol       Date:  2006-05       Impact factor: 44.182

2.  Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases.

Authors:  Donald A Collie; David M Summers; Robin J Sellar; James W Ironside; Sarah Cooper; Martin Zeidler; Richard Knight; Robert G Will
Journal:  AJNR Am J Neuroradiol       Date:  2003-09       Impact factor: 3.825

3.  Variant CJD in an individual heterozygous for PRNP codon 129.

Authors:  Diego Kaski; Simon Mead; Harpreet Hyare; Sarah Cooper; Ravi Jampana; James Overell; Richard Knight; John Collinge; Peter Rudge
Journal:  Lancet       Date:  2009-12-19       Impact factor: 79.321

4.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD.

Authors:  J Collinge; K C Sidle; J Meads; J Ironside; A F Hill
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

Review 5.  Variant Creutzfeldt-Jakob disease.

Authors:  J Collinge
Journal:  Lancet       Date:  1999-07-24       Impact factor: 79.321

6.  Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent.

Authors:  M E Bruce; R G Will; J W Ironside; I McConnell; D Drummond; A Suttie; L McCardle; A Chree; J Hope; C Birkett; S Cousens; H Fraser; C J Bostock
Journal:  Nature       Date:  1997-10-02       Impact factor: 49.962

7.  Novel proteinaceous infectious particles cause scrapie.

Authors:  S B Prusiner
Journal:  Science       Date:  1982-04-09       Impact factor: 47.728

Review 8.  Review on the epidemiology and dynamics of BSE epidemics.

Authors:  Christian Ducrot; Mark Arnold; Aline de Koeijer; Dagmar Heim; Didier Calavas
Journal:  Vet Res       Date:  2008-01-11       Impact factor: 3.683

9.  Comparative evidence for a link between Peyer's patch development and susceptibility to transmissible spongiform encephalopathies.

Authors:  Suzanne G St Rose; Nora Hunter; Louise Matthews; James D Foster; Margo E Chase-Topping; Loeske E B Kruuk; Darren J Shaw; Susan M Rhind; Robert G Will; Mark E J Woolhouse
Journal:  BMC Infect Dis       Date:  2006-01-11       Impact factor: 3.090

Review 10.  Review. The origin of the prion agent of kuru: molecular and biological strain typing.

Authors:  Jonathan D F Wadsworth; Susan Joiner; Jacqueline M Linehan; Emmanuel A Asante; Sebastian Brandner; John Collinge
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-11-27       Impact factor: 6.237

View more
  9 in total

1.  The prion protein M129V polymorphism: longevity and cognitive impairment among Polish centenarians.

Authors:  Ewa Golanska; Monika Sieruta; Elizabeth Corder; Sylwia M Gresner; Anna Pfeffer; Malgorzata Chodakowska-Zebrowska; Tomasz M Sobow; Izabela Klich; Malgorzata Mossakowska; Aleksandra Szybinska; Maria Barcikowska; Pawel P Liberski
Journal:  Prion       Date:  2013-02-13       Impact factor: 3.931

Review 2.  Interpretation of cerebrospinal fluid protein tests in the diagnosis of sporadic Creutzfeldt-Jakob disease: an evidence-based approach.

Authors:  Michael B Coulthart; Gerard H Jansen; Neil R Cashman
Journal:  CMAJ       Date:  2014-01-20       Impact factor: 8.262

3.  Could immunomodulation be used to prevent prion diseases?

Authors:  Thomas Wisniewski; Fernando Goñi
Journal:  Expert Rev Anti Infect Ther       Date:  2012-03       Impact factor: 5.091

Review 4.  Human prion diseases: surgical lessons learned from iatrogenic prion transmission.

Authors:  David J Bonda; Sunil Manjila; Prachi Mehndiratta; Fahd Khan; Benjamin R Miller; Kaine Onwuzulike; Gianfranco Puoti; Mark L Cohen; Lawrence B Schonberger; Ignazio Cali
Journal:  Neurosurg Focus       Date:  2016-07       Impact factor: 4.047

5.  A proposed mechanism for the promotion of prion conversion involving a strictly conserved tyrosine residue in the β2-α2 loop of PrPC.

Authors:  Timothy D Kurt; Lin Jiang; Cyrus Bett; David Eisenberg; Christina J Sigurdson
Journal:  J Biol Chem       Date:  2014-03-04       Impact factor: 5.157

6.  Lack of prion infectivity in fixed heart tissue from patients with Creutzfeldt-Jakob disease or amyloid heart disease.

Authors:  Suzette A Priola; Anne E Ward; Sherman A McCall; Matthew Trifilo; Young Pyo Choi; Laura Solforosi; R Anthony Williamson; Justin T Cruite; Michael B A Oldstone
Journal:  J Virol       Date:  2013-06-19       Impact factor: 5.103

7.  A clinicopathological study of selected cognitive impairment cases in Lothian, Scotland: enhanced CJD surveillance in the 65 + population group.

Authors:  Lovney Kanguru; Gemma Logan; Briony Waddel; Colin Smith; Anna Molesworth; Richard Knight
Journal:  BMC Geriatr       Date:  2022-07-20       Impact factor: 4.070

8.  Asynchronous onset of clinical disease in BSE-infected macaques.

Authors:  Judith Montag; Walter Schulz-Schaeffer; Annette Schrod; Gerhard Hunsmann; Dirk Motzkus
Journal:  Emerg Infect Dis       Date:  2013-07       Impact factor: 6.883

9.  Estimation of the exposure of the UK population to the bovine spongiform encephalopathy agent through dietary intake during the period 1980 to 1996.

Authors:  Chu-Chih Chen; Yin-Han Wang
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.